Chromadex Corp
NASDAQ:CDXC
Chromadex Corp
NASDAQ:CDXC
Price:
3.3 USD
-5.17%
Market Closed
Updated:
May 19, 2024
Chromadex Corp
Other Liabilities
|
Chromadex Corp
Other Liabilities Peer Comparison
Comparables:
TMO
DHR
MTD
A
IQV
Competitive Other Liabilities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Other Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Chromadex Corp
NASDAQ:CDXC
|
Other Liabilities
$5.7m
|
CAGR 3-Years
2%
|
CAGR 5-Years
1%
|
CAGR 10-Years
40%
|
|
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
Other Liabilities
$4.6B
|
CAGR 3-Years
12%
|
CAGR 5-Years
13%
|
CAGR 10-Years
20%
|
|
|
Danaher Corp
NYSE:DHR
|
Other Liabilities
$5.8B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
3%
|
|
|
Mettler-Toledo International Inc
NYSE:MTD
|
Other Liabilities
$306.2m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
5%
|
|
|
Agilent Technologies Inc
NYSE:A
|
Other Liabilities
$588m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-5%
|
|
|
IQVIA Holdings Inc
NYSE:IQV
|
Other Liabilities
$921m
|
CAGR 3-Years
1%
|
CAGR 5-Years
17%
|
CAGR 10-Years
18%
|
See Also
What is Chromadex Corp's Other Liabilities?
Other Liabilities
5.7m
USD
5.7m
USD
Based on the financial report for Mar 31, 2024, Chromadex Corp's Other Liabilities amounts to 5.7m USD.
What is Chromadex Corp's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
40%
40%
Over the last year, the Other Liabilities growth was -22%. The average annual Other Liabilities growth rates for Chromadex Corp have been 2% over the past three years , 1% over the past five years , and 40% over the past ten years .
You don't have any saved screeners yet
